Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04511169
Other study ID # 90483
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 20, 2020
Est. completion date March 1, 2021

Study information

Verified date May 2020
Source Haukeland University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by symptoms of inattention and/or hyperactivity/impulsivity that are persistent across situations and time. ADHD in adulthood, with an estimated prevalence of 2 - 3 %, is associated with challenges that may have severe consequences on their daily life functioning. Still, the availability of evidence-based psychological interventions is limited. Interventions delivered over the Internet is promising, because it may increase the availability of effective psychological interventions for a larger group of adults with ADHD. However, studies show that lack of sustained adherence is a challenge in self-guided internet interventions. Digital reminders may help increase adherence and engagement in these interventions.


Description:

Background: Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by symptoms of inattention and/or hyperactivity/impulsivity that are persistent across situations and time. ADHD in adulthood, with an estimated prevalence of 2 - 3 %, is associated with challenges that may have severe consequences on their daily life functioning. Still, the availability of evidence-based psychological interventions is limited. Interventions delivered over the Internet is promising, because it may increase the availability of effective psychological interventions for a larger group of adults with ADHD. However, studies show that lack of sustained adherence is a challenge in self-guided internet interventions. Digital reminders may help increase adherence and engagement in these interventions. Objectives: The overall aim of this study is to investigate adherence and effects of a self-guided Internet-delivered intervention for adults with an ADHD diagnosis. More detailed, we will examine whether the use of reminders will increase adherence and engagement in the intervention, and consequently how this affect intervention effects. Methods: The study uses a micro-randomized design. A total of 100 participants with an ADHD diagnosis will be included. Primary measure is adherence (completed modules) and participant feedback regarding self-reported engagement. Secondary clinical outcomes: inattention and hyperactivity/impulsivity measured by two subscales from the Adult ADHD Self-Rating Scale (ASRS); quality of life measured by Adult ADHD Quality of Life Measure (AAQol); stress measured by the Perceived Stress Scale (PSS); cognitive functioning measured with the Perceived Deficit Questionnaire (PDQ-5), and self-compassion measured by the Self compassion-Scale - short form (SCS-SF). We will use quantitative statistical procedures and qualitative methods to analyze the data. Discussion: The results from the study will contribute to the growing research on Internet-delivered interventions. The expected results may have a major impact on further development of treatment options for adults with ADHD. Moreover, investigating ways to increase adherence in online self-guided programs could be of great value when implementing such intervention into routine care.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date March 1, 2021
Est. primary completion date February 20, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults with a diagnosis of ADHD - Access to a computer, smartphone and the Internet. - Speaks, writes and read Norwegian Exclusion Criteria: - Current self-reported diagnosis of severe psychiatric illness (ongoing substance abuse, suicidal ideation or psychosis). - Ongoing psychological treatment for ADHD or other psychiatric illnesses.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
digital self-help
The digital self-help program is targeting every-day ADHD symptoms in adults with a diagnosed ADHD

Locations

Country Name City State
Norway Community Sample Bergen

Sponsors (2)

Lead Sponsor Collaborator
Haukeland University Hospital University of Bergen

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary number of remainders number of remainders up to 8 weeks
Secondary The Adult ADHD Self-Rating Scale includes all the 18 symptoms of ADHD included in the diagnostic manual (DSM-5). ASRS is a self-report scale with 18 items, and is divided into two subscales; one scale measuring problems with Inattention (9 questions), and one scale measuring problems with Hyperactivity (9 questions). 0 to 16 means unlikely to have ADHD, 17 to 23 means likely to have ADHD, and 24 to 36 means highly likely to have ADHD up to 40 weeks
Secondary Adult ADHD Quality of Life Measure Each item is rated by participant s on a five-point Likert scale ranging from "Not at all/ Never" (1) to "Extremely/Very Often" (5). up to 40 weeks
Secondary The perceived stress scale The Perceived Stress Scale (PSS) is a widely used psychological instrument for measuring stress. Items were designed to measure stress and how uncontrollable respondents find their lives during the last month (Cohen et al, 1983). The PSS version used in this study has 10 items with response alternatives 0 (never) to 4 (very often) and an internal reliability of a Cronbach's alpha of 0.89 (Roberti et al, 2006) up to 40 weeks
Secondary The Patient Health Questionnaire-9 The Patient Health Questionnaire-9 (PHQ-9: Kroenke et al., 2001) is a self-report tool used to assess the presence and severity of depressive symptoms. Reliability and validity of the tool have indicated it has sound psychometric properties. Internal consistency of the PHQ-9 has been shown to be high up to 40 weeks
Secondary The self-compassion scale - short form The scale includes 6 subscales that measure how often people respond to feelings of inadequacy or suffering with self-kindness, self-judgment, common humanity, isolation, mindfulness and over-identification. Questions are rated on a scale from 1 (almost never) to 5 (almost always). up to 40 weeks
Secondary The Perceived Deficits Questionnaire 5-item brief assessment of subjective cognitive difficulties and covers problems with concentration (e.g. "trouble concentrating on things like watching a television program or reading a book?"), memory (e.g. "forget what you talked about after a telephone conversation?"), and executive functioning (e.g. "have trouble getting things organized?"). Every item is rated on a scale of 0 (Never) to 4 (Almost always) to yield a sum score of 0 to 20, with higher scores indicating greater severity of cognitive symptoms. up to 40 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06465641 - Methylphenidate in KBG Syndrome: N-of-1 Series Phase 4
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Completed NCT04799886 - Attitudes Associated to Prescription of ADHD Drugs Among Child and Adolescent Psychiatrists in Region Skåne.
Completed NCT05452954 - Psychosocial ADHD Interventions - Brief Parent Training N/A
Recruiting NCT03313349 - A School-Based Intervention to Improve Social Functioning N/A
Completed NCT01727414 - Attention Deficit Disorder Medication Response Study Phase 4
Active, not recruiting NCT05930912 - Psychiatric Orders in Psychoanalytic Treatment of ASD
Recruiting NCT05924594 - Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301 Phase 3
Recruiting NCT04781972 - Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD Phase 4
Active, not recruiting NCT05286762 - Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301 Phase 3
Not yet recruiting NCT06235177 - Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues Early Phase 1
Recruiting NCT04504890 - Ocular-vestibular Biomarker Identification for ADHD
Recruiting NCT06299189 - A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care N/A
Recruiting NCT04729439 - Technology-Enhanced Executive Functioning Intervention for ADHD Phase 1
Completed NCT03335748 - the Cogmed Program for Youths With ADHD N/A
Completed NCT05631626 - Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301. Phase 3